Bookmark and Share

News Article

CER results on statin drug use are in!
A CER study by WellPoint research subsidiary HealthCore,found that people taking the most commonly used generic and branded statins to control their cholesterol had similar observable rates of cardiovascular events, but their total treatment costs were as much as 30 percent higher with branded drugs. The study used medical and pharmacy claims data from geographically diverse affiliated health plans in the United States. (Source: The Street, 6/4/12)

Read more. 
Bookmark and Share